Consumer Trends
Weight-Loss Drugs Are Quietly Reshaping the Cannabis Market
By Intent.Health Team • 2 min read
What’s happening
GLP-1 weight-loss drugs (like semaglutide-based treatments) are changing how consumers use cannabis.
Users report reduced cravings and appetite, which is directly impacting cannabis consumption patterns, especially products linked to the “munchies” effect.
What’s changing / Business impact
- Cannabis companies are shifting toward lower-dose products and non-edible formats (vapes, tinctures)
- Slower digestion from GLP-1 drugs is altering how edibles are absorbed
- Early research suggests GLP-1 drugs may even help reduce substance dependency behaviors
Why this matters
Healthcare impact doesn’t stay within healthcare.
This move signals that:
- A single drug class is now changing consumer behavior across industries
- Forcing adjacent markets to reposition products
- Creating second-order effects most companies don’t track
If you’re only watching your category, you’re missing where disruption actually starts.